CCL5 and neoplasm: Becn1/Beclin1-deficient melanoma cells in the TME expressed high levels of CCL5 via the activation of the MAPK8/JNK-JUN/c-Jun signaling pathway, which boosted the infiltration of functional NK cells into the TME and curtailed tumor progression (119).